These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11855537)

  • 1. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications.
    Dhiman RK; Saraswat VA; Naik SR
    Dig Dis Sci; 2002 Feb; 47(2):241-50. PubMed ID: 11855537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-channel ambulatory esophageal pH monitoring. A useful diagnostic tool?
    Wo JM; Hunter JG; Waring JP
    Dig Dis Sci; 1997 Nov; 42(11):2222-6. PubMed ID: 9398798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease.
    Dhiman RK; Saraswat VA; Mishra A; Naik SR
    Dig Dis Sci; 1996 Apr; 41(4):764-72. PubMed ID: 8674398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical presentation of gastroesophageal reflux disease: chest pain, pulmonary, and ear, nose, throat manifestations.
    Champion GL; Richter JE
    Gastroenterologist; 1993 Mar; 1(1):18-33. PubMed ID: 8049877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of ambulatory 24-hour esophageal pH and motility monitoring in noncardiac chest pain: report of 90 patients and review of the literature.
    Lacima G; Grande L; Pera M; Francino A; Ros E
    Dig Dis Sci; 2003 May; 48(5):952-61. PubMed ID: 12772796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraesophageal symptoms of GERD.
    DeVault KR
    Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S20-32. PubMed ID: 14705379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do.
    Streets CG; DeMeester TR
    J Clin Gastroenterol; 2003 Jul; 37(1):14-22. PubMed ID: 12811203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and clinical relevance of proximal esophageal pH monitoring.
    Cool M; Poelmans J; Feenstra L; Tack J
    Am J Gastroenterol; 2004 Dec; 99(12):2317-23. PubMed ID: 15571576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of esophageal pH monitoring in symptomatic patients on PPI therapy.
    Charbel S; Khandwala F; Vaezi MF
    Am J Gastroenterol; 2005 Feb; 100(2):283-9. PubMed ID: 15667483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of supraesophageal manifestations in patients with gastroesophageal erosive and non-erosive reflux disease].
    Aguero GC; Lemme EM; Alvariz A; Carvalho BB; Schechter RB; Abrahão L
    Arq Gastroenterol; 2007; 44(1):39-43. PubMed ID: 17639181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring.
    Gastal OL; Castell JA; Castell DO
    Chest; 1994 Dec; 106(6):1793-6. PubMed ID: 7988202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal pH monitoring, indications, and methods.
    Sarani B; Gleiber M; Evans SR
    J Clin Gastroenterol; 2002 Mar; 34(3):200-6. PubMed ID: 11873097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications, technique, and clinical use of ambulatory 24-hour esophageal motility monitoring in a surgical practice.
    Stein HJ; DeMeester TR
    Ann Surg; 1993 Feb; 217(2):128-37. PubMed ID: 8439211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management.
    Richter JE
    Gastroenterol Clin North Am; 1996 Mar; 25(1):75-102. PubMed ID: 8682579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain.
    Hewson EG; Sinclair JW; Dalton CB; Richter JE
    Am J Med; 1991 May; 90(5):576-83. PubMed ID: 2029015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of gastroesophageal reflux disease in elderly subjects using 24-hour esophageal pH monitoring.
    Wu B; Wang M; Li Y
    Chin Med J (Engl); 1999 Apr; 112(4):333-5. PubMed ID: 11593533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.